Pharmaron (03759) Completes Placement of 58.44 Million Shares, Raises Net Proceeds of HK$1.319 Billion

Stock News17:12

Pharmaron (03759) has announced that all conditions have been met and the placement was successfully completed on January 22, 2026. The placing agent, acting in accordance with the terms and conditions of the placing agreement, successfully placed a total of 58.44 million placing shares to no fewer than six independent placees at a placing price of HK$22.82 per share. The net proceeds from the placement amount to HK$1.319 billion and are intended to be used as follows: approximately 70% will be allocated to the company's project construction to enhance the capabilities and capacity of its laboratory service facilities and drug process development and manufacturing facilities; approximately 10% will be used to repay bank loans and other borrowings to optimize the company's capital structure; and the remaining 20% will be utilized to supplement working capital and for other general corporate purposes.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment